Literature DB >> 20187296

PET/CT in head and neck cancer: an update.

Roland Hustinx1, Giovanni Lucignani.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20187296     DOI： 10.1007/s00259-009-1365-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  25 in total

1.  Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium.

Authors:  David I Conway; Mia Hashibe; Paolo Boffetta; Victor Wunsch-Filho; Joshua Muscat; Carlo La Vecchia; Deborah M Winn
Journal:  Oral Oncol       Date:  2009-05-12       Impact factor: 5.337

2.  Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy.

Authors:  Amy G Rabalais; Rohan Walvekar; Daniel Nuss; Andrew McWhorter; Charles Wood; Robert Fields; Donald E Mercante; Anna M Pou
Journal:  Laryngoscope       Date:  2009-06       Impact factor: 3.325

3.  Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI.

Authors:  Piet Dirix; Vincent Vandecaveye; Frederik De Keyzer; Sigrid Stroobants; Robert Hermans; Sandra Nuyts
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

4.  Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer.

Authors:  Man Ki Chung; Han-Sin Jeong; Sang Gyu Park; Jeon Yeob Jang; Young-Ik Son; Joon Young Choi; Seung Hyup Hyun; Keunchil Park; Myung-Ju Ahn; Yong Chan Ahn; Hyung-Jin Kim; Young-Hyeh Ko; Chung-Hwan Baek
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

5.  Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer.

Authors:  Richard C W Martin; Michael Fulham; Kerwin F Shannon; Ceri Hughes; Kan Gao; Chris Milross; Mo Mo Tin; Michael Jackson; Anthony Clifford; Michael J Boyer; Christopher J O'Brien
Journal:  Head Neck       Date:  2009-02       Impact factor: 3.147

6.  Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.

Authors:  S Balogova; S Périé; K Kerrou; D Grahek; F Montravers; B Angelard; B Susini; P El Chater; J Lacau St Guily; J N Talbot
Journal:  Mol Imaging Biol       Date:  2008-07-31       Impact factor: 3.488

7.  (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.

Authors:  Stephan K Haerle; Klaus Strobel; Thomas F Hany; Daniel Sidler; Sandro J Stoeckli
Journal:  Head Neck       Date:  2010-03       Impact factor: 3.147

8.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

9.  Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning.

Authors:  Huan Yu; Curtis Caldwell; Katherine Mah; Daniel Mozeg
Journal:  IEEE Trans Med Imaging       Date:  2009-03       Impact factor: 10.048

10.  Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.

Authors:  Christine G Gourin; Brian J Boyce; Hadyn T Williams; Anne V Herdman; Paul A Bilodeau; Teresa A Coleman
Journal:  Laryngoscope       Date:  2009-11       Impact factor: 3.325
View more
  14 in total

Review 1.  Economic evaluation of nuclear medicine procedures.

Authors:  Massimo Salvatori; Marco Oradei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  Combined PET/CT-perfusion in patients with head and neck cancers.

Authors:  Patrick Veit-Haibach; Daniel Schmid; Klaus Strobel; Jan D Soyka; Niklaus G Schaefer; Stephan K Haerle; Gerhard Huber; Gabriele Studer; Burkhardt Seifert; Thomas F Hany
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

3.  Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.

Authors:  Marcelo A Queiroz; Martin Hüllner; Felix Kuhn; Gerhardt Huber; Christian Meerwein; Spyros Kollias; Gustav von Schulthess; Patrick Veit-Haibach
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-05       Impact factor: 9.236

4.  Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?

Authors:  Stephan K Haerle; G F Huber; T F Hany; N Ahmad; D T Schmid
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-03       Impact factor: 2.503

5.  Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer.

Authors:  Maria Hentschel; Steffen Appold; Andreas Schreiber; Nasreddin Abolmaali; Andrij Abramyuk; Wolfgang Dörr; Joerg Kotzerke; Michael Baumann; Klaus Zöphel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-25       Impact factor: 9.236

6.  Chimeric ferritin nanocages for multiple function loading and multimodal imaging.

Authors:  Xin Lin; Jin Xie; Gang Niu; Fan Zhang; Haokao Gao; Min Yang; Qimeng Quan; Maria A Aronova; Guofeng Zhang; Seulki Lee; Richard Leapman; Xiaoyuan Chen
Journal:  Nano Lett       Date:  2011-01-06       Impact factor: 11.189

7.  Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 Tesla.

Authors:  Julia Fruehwald-Pallamar; Christian Czerny; Marius E Mayerhoefer; Benjamin S Halpern; Christina Eder-Czembirek; Markus Brunner; Matthias Schuetz; Michael Weber; Laura Fruehwald; Andreas M Herneth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-05       Impact factor: 9.236

8.  Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.

Authors:  Christiaan Schiepers; Magnus Dahlbom
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

9.  Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?

Authors:  Stephan K Haerle; Thomas F Hany; Nader Ahmad; Irene Burger; Gerhard F Huber; Daniel T Schmid
Journal:  Cancer Imaging       Date:  2013-02-20       Impact factor: 3.909

10.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Authors:  Maliha Sadick; Stefan O Schoenberg; Karl Hoermann; Haneen Sadick
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.